Streetbeat News

Regulatory

XRPUSD

Ripple has donated an additional $25 million to the pro-crypto super PAC Fairshake, bringing its total contribution to $50 million. This move aims to influence the 2024 U.S. elections in favor of crypto-friendly regulations. Ripple's CEO, Brad Garlinghouse, emphasizes the need for a positive regulatory landscape to foster innovation in the crypto space.

Portfolio Pulse from Murtuza Merchant

May 29, 2024 | 1:04 pm

DASH

DLVHF

DROOF

JTKWY

Top food delivery companies like DoorDash, Deliveroo, Just Eat Takeaway, and Delivery Hero have reported over $20 billion in operating losses since going public. These companies are facing a challenging economic environment, leading to a decline in their stock prices. They are now exploring new revenue streams and experiencing industry consolidation.

Portfolio Pulse from Benzinga Neuro

May 29, 2024 | 12:59 pm

GV

Trading halt status updated at 8:55:00 AM ET for GV. Quotation resumption times and news updates are provided.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 12:55 pm

MIRA

Mira Pharmaceuticals announced that the DEA has ruled MIRA-55 is not classified as a controlled substance. This decision removes potential complications for the drug's manufacturing, development, and commercialization.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 12:54 pm

BTCS

BTCS and Forta have announced a partnership to enhance blockchain regulatory compliance. This collaboration aims to leverage Forta's real-time monitoring capabilities to ensure BTCS's blockchain operations meet regulatory standards.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 12:49 pm

RSLS

ReShape Lifesciences shares are trading higher after the company announced that it received a notice of allowance for its U.S. patent application 17/572,387 titled 'INTRAGASTRIC DEVICE (FOR TREATING OBESITY)'.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 12:35 pm

INBS

Intelligent Bio Solutions (INBS) has completed recruitment and begun subject screening for its FDA 510 pharmacokinetic study. This marks a significant milestone in the company's efforts to bring its product to market.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 12:35 pm

BHVN

Biohaven presented significant development and regulatory progress across various therapeutic areas at its 2024 Investor R&D Day. Key highlights include interim data from the Phase 1 study of BHV-1300, advances in ion channel programs, anticipated Phase 3 data for the Myostatin program in SMA, and promising preclinical data for taldefgrobep alfa in weight loss. Additionally, Phase 1 data for BHV-8000 showed safety and target concentration achievement.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 12:33 pm

AKLI

Trading for AKLI was halted and then resumed at 8:25:00 AM ET. The halt was due to news pending, and trading has now resumed.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 12:25 pm

ICE

The New York Stock Exchange (NYSE), part of Intercontinental Exchange, Inc. (NYSE:ICE), is collaborating with CoinDesk Indices to launch cash-settled index options tracking the CoinDesk Bitcoin Price Index (XBX). These contracts are subject to regulatory approvals.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 12:21 pm